1. Home
  2. CURI vs CCCC Comparison

CURI vs CCCC Comparison

Compare CURI & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CuriosityStream Inc.

CURI

CuriosityStream Inc.

HOLD

Current Price

$3.25

Market Cap

221.5M

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$1.89

Market Cap

177.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CURI
CCCC
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
221.5M
177.4M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CURI
CCCC
Price
$3.25
$1.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$6.00
$7.25
AVG Volume (30 Days)
460.5K
1.4M
Earning Date
03-11-2026
02-27-2026
Dividend Yield
9.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$66,595,000.00
$30,108,000.00
Revenue This Year
$42.19
N/A
Revenue Next Year
$7.94
N/A
P/E Ratio
N/A
N/A
Revenue Growth
28.62
N/A
52 Week Low
$2.06
$1.09
52 Week High
$7.15
$3.65

Technical Indicators

Market Signals
Indicator
CURI
CCCC
Relative Strength Index (RSI) 34.03 43.91
Support Level $3.03 $1.74
Resistance Level $3.40 $1.90
Average True Range (ATR) 0.17 0.12
MACD -0.03 -0.00
Stochastic Oscillator 16.46 40.56

Price Performance

Historical Comparison
CURI
CCCC

About CURI CuriosityStream Inc.

CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: